Desk› Healthcare› Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd
Filing rhythm · 60 trading days
44 filings · 7 material · busiest 2026-07-10
What it files
Filings
44 in the window
-
25 August 2026
GeneralAnnouncement Under Reg 30 (LODR) - Updates (Audited Financial Statements)
Please refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)
Company Update / General View filing →
-
25 August 2026
OutcomeBoard Meeting Outcome for Outcome Of Board Meeting Related To QIP
Please refer to the attachment
Others / Outcome without intimation View filing →
-
14 August 2026
Concall TranscriptEarnings Call Transcript
Earnings Call Transcript
Company Update / Earnings Call Transcript View filing →
-
10 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Please refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday, August 10, 2026 (IST).
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026
Please refer to the outcome of the Board meeting held on 07.08.2026
Board Meeting / Outcome of Board Meeting View filing →
-
7 August 2026
ResultsResults- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026
Please refer to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June ,2026
Result / Financial Results View filing →
-
7 August 2026
Investor PresentationInvestor Presentation
Please refer to our investors presentation for the quarter ended 30.06.2026
Company Update / Investor Presentation View filing →
-
5 August 2026
SASTDisclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 View filing →
-
4 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Please refer to the concall invite to discuss the 1QFY27 Financial performance.
Company Update / Analyst / Investor Meet View filing →
-
31 July 2026
Board MeetingBoard Meeting Intimation for Approval Of Un-Audited Financial Results And Limited Review Report Of Statutory Auditor For The Quarter Ended 30.06.2026
Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....
Board Meeting / Board Meeting View filing →
-
31 July 2026
AGM / EGMNotice Of Extra-Ordinary General Meeting On 22.08.2026
Please refer to the attachment.
AGM/EGM / EGM View filing →
-
24 July 2026
Newspaper PublicationNewspaper Publication
Please refer to our copies of Newspaper Publication dated 24.07.2026 for Postal Ballot.
Company Update / Newspaper Publication View filing →
-
23 July 2026
Postal BallotShareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please refer to the Notice of Postal Ballot 22.07.2026
AGM/EGM / Postal Ballot View filing →
-
21 July 2026
SASTRevised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Pharmaceutical ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 July 2026
SASTRevised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Themis Medicare Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 July 2026
SASTRevised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Pharmaceutical ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
21 July 2026
SASTRevised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
20 July 2026
Credit RatingCredit Rating
Please refer to the attachment.
Company Update / Credit Rating View filing →
-
17 July 2026
SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Pharmaceutical Business ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 July 2026
SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Themis Medicare Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 July 2026
Credit RatingCredit Rating
Intimation of revision in credit rating
Company Update / Credit Rating View filing →
-
15 July 2026
SASTUpdates on revised Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the updates on revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) ....
Insider Trading / SAST / Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 View filing →
-
13 July 2026
GeneralUpdates On Arbitration Matter.
Please refer to our intimation under Regulation 30 (LODR) -Updates on Arbitration matter.
Company Update / General View filing →
-
10 July 2026
Postal BallotShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Please refer to our Postal Ballot Outcome dated 8th July, 2026
AGM/EGM / Postal Ballot View filing →
-
10 July 2026
Postal BallotShareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please refer to our Scrutinizer's Report and Voting Results of Postal Ballot dated 8th July, 2026.
AGM/EGM / Postal Ballot View filing →
-
10 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer to attached Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
10 July 2026
Postal BallotShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Please refer to the attachment.
AGM/EGM / Postal Ballot View filing →
-
10 July 2026
Postal BallotShareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please refer to the attachment.
AGM/EGM / Postal Ballot View filing →
-
2 July 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
2 July 2026
SASTDisclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Insider Trading / SAST / Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 View filing →
-
1 July 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 July 2026
SASTDisclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 View filing →
-
29 June 2026
Investor PresentationInvestor Presentation
Please refer to the attachment.
Company Update / Investor Presentation View filing →
-
26 June 2026
-
25 June 2026
Trading WindowClosure of Trading Window
Intimation of closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 June 2026
SASTDisclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Insider Trading / SAST / Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 View filing →
-
17 June 2026
GeneralAnnouncement Under Regulation 30 - Updates
Please refer to the attachmnet
Company Update / General View filing →
-
17 June 2026
Board MeetingCancellation of Board Meeting
The Board Meeting to be held on 19/06/2026 Stands Cancelled.
Company Update / Board Meeting Cancelled View filing →
-
16 June 2026
Board MeetingBoard Meeting Intimation for Inter Alia, To Evaluate Proposal For Raising Funds Through Issue Of Equity Shares / Securities Inc luding Compulsory Convertible Debentures, Optionally Convertible Debentures And Non-Convertible Debentures..
Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/06/2026 ,inter alia, to consider and approve the proposal for raising ....
Board Meeting / Board Meeting View filing →
-
9 June 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication of Postal Ballot Notice dated 6th June, 2026
Company Update / Newspaper Publication View filing →
-
8 June 2026
Postal BallotShareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please refer to the attachment.
AGM/EGM / Postal Ballot View filing →
-
5 June 2026
Postal BallotShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Please refer to Voting Results and Scrutinizer's Report on Postal Ballot dated 4th June, 2026
AGM/EGM / Postal Ballot View filing →
-
5 June 2026
Postal BallotShareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results on Postal Ballot through e-voting and Scrutinizer's Report dated 04th June, 2026.
AGM/EGM / Postal Ballot View filing →
-
3 June 2026
Board MeetingBoard Meeting Intimation for Consideration And Evaluate The Proposals For Raising Funds By Way Of Issue Of Equity Shares / Securities Through Qualified Institutions Placement Or Preferential Allotment Or Any Other Methods / Modes Or Combination Thereof.
Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/06/2026 ,inter alia, to consider and approve the proposals for raising ....
Board Meeting / Board Meeting View filing →